Literature DB >> 23579404

Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome.

K A Gonen1, T Gonen, B Gumus.   

Abstract

PURPOSE: To evaluate the renal arteries and abdominal aorta in patients with pseudoexfoliation syndrome (PEX).
DESIGN: Prospective, case-control study.
METHODS: The study involved 49 patients with PEX and 42 control subjects. Abdominal aorta and renal arteries were examined by Doppler ultrasonography. In both renal arteries (proximal and distal portions) and abdominal aorta, the peak systolic velocity (PSV) was measured. Renal artery stenosis (RAS) was defined as the renal artery PSV >150 cm/s or renal-to-aortic ratio (RAR) >3.0. Patients who had an abdominal aortic diameter >3 cm were recorded. Computed tomographic angiography was performed to confirm these findings in patients with RAS and/or abdominal aorta aneurysm.
RESULTS: The mean PSV in the proximal renal artery was 88.3 cm/s in PEX group and 79.5 cm/s in control group (P=0.314); in distal renal artery was 91.7 cm/s in PEX group and 93.0 cm/s in control group (P=0.794); in abdominal aorta was 76.0 cm/s in PEX group and 65.2 cm/s in control group (P=0.046). RAS was observed in nine patients with PEX and in only one patient without PEX (P=0.017). Seven out of 10 patients with RAS (six patients in PEX group; one patient in control group) had hypertension. Abdominal aorta aneurysm was observed in four patients in PEX group but not in control group (P=0.061).
CONCLUSIONS: Our study has demonstrated that there is a significant association between PEX and RAS. The abdominal aorta aneurysm may be seen in patients with PEX.

Entities:  

Mesh:

Year:  2013        PMID: 23579404      PMCID: PMC3682361          DOI: 10.1038/eye.2013.56

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  40 in total

1.  Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm.

Authors:  Jaana Hietanen; Sari Soisalon-Soininen; Tero Kivelä; Ahti Tarkkanen
Journal:  Acta Ophthalmol Scand       Date:  2002-12

Review 2.  The ultrastructural changes in the exfoliation syndrome.

Authors:  J H Seland
Journal:  Acta Ophthalmol Suppl       Date:  1988

3.  Pseudoexfoliation and sensorineural hearing loss.

Authors:  M Cahill; A Early; S Stack; A W Blayney; P Eustace
Journal:  Eye (Lond)       Date:  2002-05       Impact factor: 3.775

4.  Renal duplex sonography: evaluation of clinical utility.

Authors:  K J Hansen; R W Tribble; S W Reavis; V J Canzanello; T E Craven; G W Plonk; R H Dean
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

5.  Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.

Authors:  J S Ritland; K Egge; S Lydersen; R Juul; S O Semb
Journal:  Acta Ophthalmol Scand       Date:  2004-08

Review 6.  Imaging of renovascular disease.

Authors:  Ravinder Sidhu; Mark E Lockhart
Journal:  Semin Ultrasound CT MR       Date:  2009-08       Impact factor: 1.875

7.  Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group.

Authors:  M Claudon; P F Plouin; G M Baxter; T Rohban; D M Devos
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

8.  Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.

Authors:  B W Streeten; Z Y Li; R N Wallace; R C Eagle; A A Keshgegian
Journal:  Arch Ophthalmol       Date:  1992-12

Review 9.  Hypertension due to renal arterial disease.

Authors:  D Aristizabal; E D Frohlich
Journal:  Heart Dis Stroke       Date:  1992 Jul-Aug

10.  Prevalence and early detection of abdominal aortic aneurysm in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.

Authors:  Jasmina Djordjevic-Jocic; Predrag Jovanovic; Marija Bozic; Aleksandar Tasic; Zoran Rancic
Journal:  Curr Eye Res       Date:  2012-05-10       Impact factor: 2.424

View more
  14 in total

1.  Pseudoexfoliation syndrome and cardiovascular disease: studies must control for all cardiovascular risk factors.

Authors:  I H Yusuf
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

2.  Reply: Pseudoexfoliation syndrome and cardiovascular disease: studies must control for all cardiovascular risk factors.

Authors:  K A Gonen; T Gonen; B Gumus
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

3.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

4.  YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome.

Authors:  Tansu Gonen; Savas Guzel; Kadircan H Keskinbora
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

5.  Macula Vessel Density and Foveal Avascular Zone Parameters in Exfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.

Authors:  Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

6.  De novo variants in an extracellular matrix protein coding gene, fibulin-5 (FBLN5) are associated with pseudoexfoliation.

Authors:  Biswajit Padhy; Ramani Shyam Kapuganti; Bushra Hayat; Pranjya Paramita Mohanty; Debasmita Pankaj Alone
Journal:  Eur J Hum Genet       Date:  2019-07-29       Impact factor: 4.246

Review 7.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 8.  Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease.

Authors:  Juan A Siordia; Jimena Franco; Todd R Golden; Bilal Dar
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

9.  Serum Uric Acid, Alanine Aminotransferase, Hemoglobin and Red Blood Cell Count Levels in Pseudoexfoliation Syndrome.

Authors:  Hüseyin Simavlı; Yasin Yücel Bucak; Mehmet Tosun; Mesut Erdurmuş
Journal:  J Ophthalmol       Date:  2015-05-13       Impact factor: 1.909

10.  Ocular pseudoexfoliation syndrome and life span.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  EBioMedicine       Date:  2015-05-30       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.